Diagnostics

News and analysis on diagnostic technologies and applications.

The immunohistochemistry-based CDx will operate on the Roche BenchMark ULTRA instrument.

The company said it will sell off the businesses in order to focus on in vitro diagnostic product development and its diagnostic reagent units.

By achieving certification for the assay, called PredictSure IBD, the Cambridge, UK-based firm can sell it for clinical use across Europe.

The firm said clinical services revenues fell during the quarter due to reduced insurance reimbursement payments and mix of testing in the prior year.

The quantitative immunoassay measures the concentration of a novel antibiotic, plazomicin (Zemdri), using the automated clinical chemistry analyzer Beckman Coulter AU 680.